Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
Recombinant factor VIIa (rFVIIa) is registered for use in haemophilia with inhibitors and other rare bleeding disorders, but has also been used in various other clinical conditions to terminate life-threatening bleeding. Underlying conditions (e.g. coagulopathy) and dosing may affect treatment effic...
Main Authors: | Henri M H Spronk, Till Braunschweig, Rolf Rossaint, Dirk C Wüst, Rene van Oerle, Brian Lauritzen, Rene Tolba, Oliver Grottke |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4476676?pdf=render |
Similar Items
-
Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model.
by: Oliver Grottke, et al.
Published: (2013-01-01) -
Low-dose recombinant factor VIIa for massive bleeding
by: A Mordasini, et al.
Published: (2011-07-01) -
The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition
by: Rolf Rossaint, et al.
Published: (2023-03-01) -
The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition
by: Donat R. Spahn, et al.
Published: (2019-03-01) -
Use of Recombinant Factor VIIa in Gastrointestinal Bleeding in Children with Malignancies: A Case Series
by: Jan Hau Lee MBBS, MRCPCH, et al.
Published: (2010-06-01)